DPP4 and acute lymphoblastic leukemia: Although CD26/DPP4 surface expression in B-ALL, AML, and T-ALL was comparable to levels observed in patients with non-leukemic hematologic alterations or in healthy controls, plasma CD26/DPP4 activity was significantly higher in leukemia patients [119].